Synthesis and Application of a Multi-Signal Fluorescent Probe that Simultaneously Distinguishes Cysteine, Homocysteine, Glutathione, and Amyloid

By synthesizing multi-channel fluorescent probes, the detection and imaging of Cys, Hcy, GSH and amyloid proteins can be achieved by utilizing different excitation wavelengths and fluorescence signal changes. This solves the problem of insufficient discrimination in existing technologies and realizes high-sensitivity multi-channel detection and imaging.

CN118084882BActive Publication Date: 2026-11-17HUNAN NORMAL UNIVERSITY
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202410302179.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-03-18
Publication Date
2026-11-17
Estimated Expiration
2044-03-18

AI Technical Summary

Technical Problem

Existing technologies lack fluorescent probes that can simultaneously and efficiently distinguish and detect intracellular cysteine ​​(Cys), homocysteine ​​(Hcy), glutathione (GSH), and amyloid protein, and their discrimination is insufficient.

Method used

A multichannel fluorescent probe was synthesized to differentiate and detect Cys, Hcy, GSH, and amyloid protein using different excitation wavelengths. Different fluorescence signal changes were generated by utilizing multiple binding sites, including Cys emitting 446 nm blue light under 380 nm excitation, GSH emitting 535 nm green light under 420 nm excitation, Hcy emitting 622 nm red light under 480 nm excitation, and amyloid protein emitting 721 nm near-infrared light under 650 nm excitation.

Benefits of technology

It achieves highly sensitive differentiation and imaging of Cys, Hcy, GSH and amyloid proteins, with low detection limits and no obvious response to other substances, making it suitable for multi-channel fluorescence imaging of live cells.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118084882B_ABST
    Figure CN118084882B_ABST
Patent Text Reader

Abstract

This invention discloses a four-color fluorescent probe that simultaneously distinguishes cysteine ​​(Cys), homocysteine ​​(Hcy), glutathione (GSH), and amyloid protein using four different fluorescence emission signals: blue, red, green, and pink. The chemical structure of the fluorescent probe is as follows: Under different excitation conditions, the probe utilizes multiple binding sites to react with cysteine, homocysteine, glutathione, and amyloid protein through different binding mechanisms, generating different fluorescent substances. This results in the emission of four different colors of fluorescence—blue, red, green, and pink—at a specific excitation wavelength, achieving the purpose of distinguishing and detecting Cys, Hcy, GSH, and amyloid protein. After reacting with Cys, the probe emits 446 nm blue light at an excitation wavelength of 380 nm; after reacting with GSH, it emits 535 nm green light at an excitation wavelength of 420 nm; after reacting with Hcy, it emits 622 nm red light at an excitation wavelength of 480 nm; and after reacting with amyloid protein, it emits 721 nm near-infrared fluorescence at an excitation wavelength of 650 nm. This probe has advantages such as high sensitivity, good selectivity, and high discrimination, and has great application prospects in analytical chemistry, life sciences, environmental sciences and other technical fields.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of analytical chemistry technology, specifically relating to the synthesis of a fluorescent probe and the application of the fluorescent probe in the simultaneous detection of cysteine ​​(Cys), homocysteine ​​(Hcy), glutathione (GSH) and amyloid in the environment, and multi-channel fluorescence imaging of endogenous and exogenous Cys, Hcy, GSH and amyloid in cells. Background Technology

[0002] Cysteine ​​(Cys), homocysteine ​​(Hcy), and glutathione (GSH) are the three most abundant small-molecule biothiols in cells, playing important roles in maintaining cell morphology and basic functions, and are closely related to many diseases (Chinese Chemical Letters, 2019, 30 (3): 563-565). Cys is a raw material for the synthesis of many proteins, and abnormal concentrations of Cys can lead to cardiovascular and liver dysfunction in humans (Chem. Commun. 2015, 51, 4245-4248). GSH is the most abundant low-molecular-weight biothiols in cells, playing an important role in maintaining the dynamic balance of cellular redox and in physiological activities such as gene regulation. When the level of Hcy in the body is too high, it may lead to coronary heart disease, Alzheimer's disease, and cardiovascular diseases (Bioorganic & Medicinal Chemistry Letters, 2019, 29(15): 1957-1961). Alzheimer's disease (AD) is an insidious, progressive neurodegenerative disease, and amyloid protein deposition is considered one of the main causes, appearing in the early stages of the disease. Recent research has confirmed that amyloid protein has been shown to be the most neurotoxic compound, exhibiting strong neurotoxic effects after deposition and accumulation in the hippocampus of the brain. It causes neuronal death and Tau protein hyperphosphorylation, leading to cognitive decline, and is considered an early pathological sign of AD (Chemical Society Reviews 2017, 46, 310-323). Therefore, the simultaneous differential detection of Cys, Hcy, GSH, and amyloid protein in vivo is of great significance.

[0003] In recent years, numerous fluorescent probes have been developed to detect these biothiols, most of which are for single or dual detection of biothiols. Fluorescent probes capable of simultaneously distinguishing Cys, Hcy, and GSH are relatively rare, and their discriminative power is somewhat lacking. It is well known that Cys, Hcy, and GSH all possess thiol and amino groups, giving them a certain degree of similarity. However, due to differences in their spatial structures, they may react with fluorescent probes at multiple binding sites, producing different reaction products through different binding mechanisms, thus leading to variations in the system's color and fluorescence signal. Summary of the Invention

[0004] In view of the above, and to overcome the shortcomings of the prior art, the purpose of this invention is to provide a multi-channel fluorescent probe for distinguishing and detecting Cys, Hcy, GSH and amyloid proteins, providing some analytical detection methods and ideas for fields such as analytical detection and environmental science.

[0005] The present invention also aims to provide a simple method for the synthesis and application of fluorescent probes.

[0006] The specific technical solution adopted by this invention to solve the problem is the synthesis of a fluorescent probe and its application in simultaneously distinguishing and detecting Cys, Hcy, GSH and amyloid proteins. The chemical structural formula of the fluorescent probe is as follows:

[0007] 2. The synthesis of the fluorescent probe according to claim 1, characterized in that the preparation method of the fluorescent probe includes the following steps: Step 1. Synthesis of 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide. a. Dissolve an appropriate amount of 5-carboxy-1-ethyl-2,3,3-trimethyl-3H-indole iodide and an appropriate amount of (E)-3-(4-(dimethylamino)phenyl)propenal in anhydrous ethanol, add an appropriate amount of piperidine, and stir the reaction at 50 degrees Celsius. b. After the reaction is complete, the mixture is filtered to obtain a blue solid 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide.

[0008] Step 2. Synthesis of (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide a. Dissolve an appropriate amount of 4-(butylthio)-7-(diethylamino)-2-oxo-2h-chromene-3-aldehyde and an appropriate amount of 4-(2-ethoxy-2-oxoethyl)-1-(2-hydroxyethyl)pyridine iodide in 10 mL of anhydrous ethanol, and stir the reaction at 50 degrees Celsius. b. After the reaction is complete, the reaction solution is evaporated to dryness under reduced pressure and column chromatography is used to obtain a dark red solid (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide.

[0009] Step 3. Synthesize the fluorescent probe. Dissolve an appropriate amount of 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide in 6 mL of anhydrous DCM, add an appropriate amount of 4-dimethylaminopyridine (DMAP), stir at room temperature for 10-15 minutes, then add an appropriate amount of (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide and an appropriate amount of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI), stir at room temperature for 2 hours, and after the reaction is complete, purify the crude product by column chromatography to obtain the blue solid, which is the fluorescent probe.

[0010] The fluorescent probe of this invention can simultaneously distinguish Cys, Hcy, GSH and Aβ. 42 Amyloid protein usage method: Unless otherwise specified, the probe molecule is usually dissolved at room temperature in an environment with an organic phase and an aqueous phase volume ratio of 5:5 for analysis and detection. The organic phase is dimethyl sulfoxide (DMSO), and the aqueous phase is phosphate buffered solution (PBS) at pH 7.4 and an aqueous solution of the analyte.

[0011] The specific characteristics of the fluorescent probe of this invention are as follows: The molecular fluorescent probe is dissolved in dimethyl sulfoxide (DMSO). The probe is dissolved in an organic phase (DMSO) and an aqueous phase (PBS) (5:5, v / v). After reacting with Cys at 37°C for 30 minutes, it emits strong blue fluorescence at 446 nm under an excitation wavelength of 380 nm; after reacting with GSH at 37°C for 30 minutes, it emits strong green fluorescence at 535 nm under an excitation wavelength of 420 nm; after reacting with Hcy at 37°C for 30 minutes, it emits red fluorescence at 622 nm under an excitation wavelength of 480 nm; and after reacting with Aβ… 42After reacting at 37°C for 30 minutes, amyloid protein emits near-infrared fluorescence at an excitation wavelength of 650 nm, while the probe itself shows no obvious fluorescence. Therefore, it is possible to detect specific analytes using specific excitation and fluorescence emission signals. The aforementioned fluorescent probe can distinguish between Cys, Hcy, GSH, and amyloid protein under different excitation conditions. It shows no significant response to amino acids such as Asp, Pro, Glu, Tyr, Ser, Val, Ala, Leu, Thr, and Dop, sulfur-containing derivatives, and other reactive oxygen species, and has low detection limits for Cys, Hcy, GSH, and amyloid protein. Therefore, the fluorescent probe disclosed in this invention can effectively detect Cys, Hcy, GSH, and Aβ. 42 Highly sensitive detection and imaging of amyloid protein. Attached Figure Description

[0012] Figure 1 This is the proton NMR spectrum of the fluorescent probe of the present invention.

[0013] Figure 2 The graph shows the change in fluorescence emission intensity with Hcy concentration in the quantitative detection of Hcy using the fluorescent probe of the present invention. The horizontal axis represents wavelength, and the vertical axis represents fluorescence intensity.

[0014] Figure 3 The graph shows the change in fluorescence emission intensity of the fluorescent probe of the present invention with the concentration of Cys in quantitative detection. The horizontal axis represents wavelength and the vertical axis represents fluorescence intensity.

[0015] Figure 4 The graph shows the change in fluorescence emission intensity with GSH concentration in the quantitative detection of GSH using the fluorescent probe of the present invention. The horizontal axis represents wavelength, and the vertical axis represents fluorescence intensity.

[0016] Figure 5 The graph shows the change in fluorescence emission intensity of the fluorescent probe of the present invention with the concentration of amyloid protein in quantitative detection. The horizontal axis represents wavelength and the vertical axis represents fluorescence intensity.

[0017] Figure 6 The fluorescent probe of this invention can simultaneously distinguish between endogenous and exogenous Cys, Hcy, GSH, and amyloid proteins in HeLa cells. Detailed Implementation

[0018] The present invention will now be further described with reference to the accompanying drawings.

[0019] The synthesis route of the fluorescent probe described in this invention is shown in the figure below:

[0020] Example 1. Synthesis of 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide a. Dissolve 1.02 g (2.84 mmol) of 5-carboxy-1-ethyl-2,3,3-trimethyl-3H-indole iodide and 676.71 mg (3.86 mmol) of (E)-3-(4-(dimethylamino)phenyl)propenal in 10 mL of anhydrous ethanol, add 30 mg of piperidine, and stir the reaction at 50 °C for 10 hours; b. After the reaction was complete, the mixture was filtered to obtain 1.05 g of blue solid 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide, with a yield of 71.6%.

[0021] Example 2. Synthesis of (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide a. Dissolve 1.06 g (3.18 mmol) 4-(butylthio)-7-(diethylamino)-2-oxo-2h-chromen-3-aldehyde and 1.07 g (3.18 mmol) 4-(2-ethoxy-2-oxoethyl)-1-(2-hydroxyethyl)pyridine iodide in 10 mL of anhydrous ethanol, and stir the reaction at 50°C for 10 hours; b. After the reaction was complete, the reaction solution was evaporated to dryness under reduced pressure, and column chromatography was performed to obtain 1.36 g of a deep red solid (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide, with a yield of 65.6%.

[0022] Example 3. Synthesis of the fluorescent probe. Dissolve 600.00 mg (1.16 mmol) of 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide in 6 mL of anhydrous DCM, add 71.00 mg (580.92 μmol) of 4-dimethylaminopyridine (DMAP), stir at room temperature for 10-15 minutes, then add 759.00 mg (1.16 mmol) of (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide and 758.20 mg (1.16 mmol) of 4-dimethylaminopyridine (DMAP). The crude product was reacted with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) at mmol for 2 hours at room temperature with stirring. After the reaction was complete, the crude product was purified by column chromatography to obtain a blue solid, namely 612.16 mg of the fluorescent probe, with a yield of 45.7%.

[0023] Example 4. Detection of Cys, Hcy, GSH, and Aβ by fluorescent molecular probes in vitro. 42 Application of amyloid protein The fluorescent probe spectral property experiment of the present invention: The probe is dissolved in dimethyl sulfoxide (DMSO) to prepare a 1 mM probe solution. 10 mM aqueous solutions of Cys, Hcy, GSH, and amyloid protein are prepared separately. The specific testing method is as follows: Take 20 μL of the 1 mM probe solution, 980 μL of analytical grade dimethyl sulfoxide, 980 μL of PBS buffer solution, and the required 10 mM aqueous solutions of Cys, Hcy, GSH, and amyloid protein (20 μL). All tests maintain a 5:5 volume ratio of organic phase to aqueous phase (total volume of each test sample is 2 mL). For example, when testing the fluorescence intensity after the probe reacts with Cys at a Cys concentration of 10 μM, the sample preparation is as follows: Take 20 μL of the 1 mM probe solution, 980 μL of analytical grade dimethyl sulfoxide, 20 μL of 10 mM Cys aqueous solution, and 980 μL of PBS buffer solution... In a mL sample tube, shake well at 37°C for 30 minutes, then measure the fluorescence emission intensity using an excitation wavelength of 380 nm. Other testing procedures are similar to those described above. This probe molecule enables the differentiation and detection of Cys, Hcy, GSH, and Aβ using different excitation wavelengths and fluorescence emission signals. 42 Amyloid protein, with high sensitivity and low detection limit, is ideally suited for detecting endogenous Cys, Hcy, GSH, and Aβ in live cells. 42 Imaging and analysis of amyloid protein.

[0024] Example 8. Endogenous and exogenous Cys, Hcy, GSH, and Aβ in HeLa (human cervical cancer cells) 42 Amyloid multichannel fluorescence imaging analysis HeLa cells were passaged into confocal culture dishes and cultured under standard growth conditions for 24 hours. Then, a suitable amount of probe (5 μM) was added, and the cells were cultured under standard growth conditions for another 30 minutes. Finally, images were taken under a confocal fluorescence microscope, using blue, red, green, and pink fluorescence channels to visualize the endogenous Cys, Hcy, GSH, and Aβ levels in the HeLa cells. 42 amyloid protein, from Figure 6 As can be seen, the multi-detection fluorescent probe of this invention successfully detects both endogenous and exogenous Cys, Hcy, GSH, and Aβ in cells. 42 Multichannel fluorescence imaging analysis of amyloid protein has great application value in fields such as biochemistry and analytical detection.

[0025] The present invention provides the synthesis of fluorescent probes and their ability to simultaneously distinguish and detect cysteine ​​(Cys), homocysteine ​​(Hcy), glutathione (GSH), and Aβ. 42 The application method in amyloid protein utilizes the multiple binding sites of the probe itself and generates different reaction products through different binding mechanisms, thereby leading to different color and fluorescence signal changes in the system (Cys blue light, Hcy red light, GSH green light, and Aβ). 42 (Amyloid protein fluorescence). This probe enables simultaneous detection and imaging of Cys, Hcy, GSH, and amyloid proteins in environmental and biological samples. It boasts advantages such as high efficiency, simplicity, low cost, and high sensitivity, and is expected to provide insights for the future development of multi-channel fluorescent probes. Although the invention has been described in detail through the above preferred embodiments, it should be understood that the above description should not be considered as limiting the invention. Various modifications and substitutions to the invention will be apparent to those skilled in the art after reading the above. Therefore, the synthesis of the fluorescent probe with the technical features described herein and its application in simultaneously distinguishing and detecting hydrogen sulfide and hydrogen peroxide fall within the protection scope of this patent.

Claims

1. The chemical structure of the fluorescent probe that simultaneously distinguishes between cysteine, homocysteine, glutathione and amyloid is shown in (1): (1)。 2. The synthesis of the fluorescent probe as described in claim 1, characterized in that, The preparation method of the fluorescent probe includes the following steps: Step 1. Synthesis of 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide. a. Dissolve an appropriate amount of 5-carboxy-1-ethyl-2,3,3-trimethyl-3H-indole iodide and an appropriate amount of (E)-3-(4-(dimethylamino)phenyl)propenal in anhydrous ethanol, add an appropriate amount of piperidine, and stir the reaction at 50 degrees Celsius. b. After the reaction is complete, the mixture is filtered to obtain a blue solid 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide. Step 2. Synthesis of (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide a. Dissolve an appropriate amount of 4-(butylthio)-7-(diethylamino)-2-oxo-2h-chromene-3-aldehyde and an appropriate amount of 4-(2-ethoxy-2-oxoethyl)-1-(2-hydroxyethyl)pyridine iodide in 10 mL of anhydrous ethanol, and stir the reaction at 50 degrees Celsius. b. After the reaction was complete, the reaction solution was evaporated to dryness under reduced pressure and column chromatography was used to obtain a deep red solid (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide; Step 3. Synthesize the fluorescent probe. Dissolve an appropriate amount of 5-carboxy-2-((1E,3E)-4-(4-(dimethylamino)phenyl)but-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indole iodide in 6 mL of anhydrous DCM, add an appropriate amount of 4-dimethylaminopyridine, stir at room temperature for 10-15 minutes, then add an appropriate amount of (Z)-4-(1-(4-(butthio)-7-(diethylamino)-2-oxo-2H-chromen-3-yl)-3-ethoxy-3-oxoprop-1-en-2-yl)-1-(2-hydroxyethyl)pyridine iodide and an appropriate amount of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, stir at room temperature for 2 hours, and after the reaction is complete, purify the crude product by column chromatography to obtain the blue solid, which is the fluorescent probe.

3. The application of the fluorescent probe as described in claim 1 in device fabrication, characterized in that, The fabricated device is capable of quantitatively detecting Cys, Hcy, GSH and Aβ42 amyloid proteins in the environment, and simultaneously differentiating and imaging Cys, Hcy, GSH and Aβ42 amyloid proteins in human cervical cancer cells.

Citation Information

Patent Citations

  • Synthesis of multi-signal fluorescent probe and application of multi-signal fluorescent probe in simultaneously distinguishing Hcy, Cys, SO2 and GSH

    CN114249743A

  • Synthesis and application of bifunctional fluorescent probe for simultaneously detecting homocysteine and viscosity

    CN117229279A